This paper uses a novel database composed of 4,262 European chemical patents applied for by 693 firms during 1987-1996 to compare the relative effect of firm and regional characteristics on the production of technological hits (highly cited patents). By using an extensive set of controls, the main finding of the paper is that in the “traditional” chemical sectors technological hits are explained only by firm-level economies of scale and scope in R&D. Firm competencies – i.e. technological specialisation – are still important in biotechnology. However, what really distinguishes the biotech model is that localised knowledge spillovers also matter. I argue that the centrality of firms vis-à-vis regions underlines a more general contrast between two different models of producing innovations.
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
Publisher Info
Paper provided by Maastricht : MERIT, Maastricht Economic Research Institute on Innovation and Technology in its series Research Memoranda with number
003.